Rho GTPases, statins, and nitric oxide.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation Research

• Publication date

  2005-12-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.RES.0000196564.18314.23PMID 16339495PMCID PMC2633589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of PTEN by Rho small GTPases

  2005cited by this paper
• ROCKs as therapeutic targets in cardiovascular diseases

  2005cited by this paper
• Simvastatin Versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans

  2005cited by this paper
• Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway.

  2005cited by this paper
• Long-Term Inhibition of RhoA Attenuates Vascular Contractility by Enhancing Endothelial NO Production in an Intact Rabbit Mesenteric Artery

  2005cited by this paper
• Inhibition of Rho Kinase (ROCK) Leads to Increased Cerebral Blood Flow and Stroke Protection

  2005cited by this paper
• Pleiotropic effects of statins.

  2005cited by this paper
• Inhibition of Rho-Kinase Leads to Rapid Activation of Phosphatidylinositol 3-Kinase/Protein Kinase Akt and Cardiovascular Protection

  2004cited by this paper
• Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors.

  2004cited by this paper
• Isoprenoid metabolism and the pleiotropic effects of statins

  2003cited by this paper
• Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase

  2002cited by this paper
• Rho GTPase/Rho Kinase Negatively Regulates Endothelial Nitric Oxide Synthase Phosphorylation through the Inhibition of Protein Kinase B/Akt in Human Endothelial Cells

  2002cited by this paper
• HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.

  2001cited by this paper
• Cerivastatin prevents tumor necrosis factor-alpha-induced downregulation of endothelial nitric oxide synthase: role of endothelial cytosolic proteins.

  2001cited by this paper
• Thrombin Suppresses Endothelial Nitric Oxide Synthase and Upregulates Endothelin-Converting Enzyme-1 Expression by Distinct Pathways: Role of Rho/ROCK and Mitogen-Activated Protein Kinase

  2001cited by this paper
• ERRATA

  2001cited by this paper
• Pleiotropic effects of statins

  2000cited by this paper
• Neuroprotection mediated by changes in the endothelial actin cytoskeleton.

  2000cited by this paper
• Decrease of endothelial nitric oxide synthase in stroke-prone spontaneously hypertensive rat cerebral cortex.

  2000cited by this paper
• The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

  2000cited by this paper
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

  1998cited by this paper
• Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase*

  1998cited by this paper
• Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

  1998cited by this paper
• Rho GTPases and signaling networks.

  1997cited by this paper
• Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase*

  1997cited by this paper
• Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans.

  1997cited by this paper
• Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month.

  1997cited by this paper
• The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion:

  1996cited by this paper
• Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

  1995cited by this paper
• The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study.

  1990cited by this paper
• Premature mortality from coronary heart disease. The Framingham study.

  1971cited by this paper

• INFLUENCE OF PTERIDINES AND STATINS ON CANCER- A THERAPEUTIC STRATEGY TARGETING NITRIC OXIDE SYNTHASE (NOS) PATHWAY

  2026cites this paper
• Convergent Metabolic Pathways in MASH Therapeutics: An AMPK‐Centric Analysis

  2026cites this paper
• Synergistic neuroprotective effects of the ROCK inhibitor Y27632 and atorvastatin in Optineurin-E50K-mutant mice through inhibition of scleral fibroblast transdifferentiation.

  2025cites this paper
• Rho/ROCK Pathway as a Therapeutic Target in Multiple Diseases

  2025cites this paper
• Statins: bitter enemies of tendons or not? A systematic review of clinical evidence.

  2025influential citation
• Regulatory effects of resveratrol on nitric oxide signaling in cardiovascular diseases

  2025cites this paper
• Non-Anticoagulation Strategies Aimed at Primary Stroke Prevention in Nascent Atrial Fibrillation

  2025cites this paper
• Coronary Artery Spasm: From Physiopathology to Diagnosis

  2025cites this paper
• Characterizing Stroke-related Cellular Changes in the Surviving Neurons of Mouse Ischemic Stroke.

  2025cites this paper
• Molecular mechanisms underlying the effects of statins on bone metabolism: an evolving paradigm of statins delivery modalities for bone regeneration

  2025cites this paper
• Impact of statins on mortality and disease progression in patients with Alzheimer's disease: a nationwide cohort study.

  2025cites this paper
• The pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood–brain barrier protection

  2024influential citation
• The Effect of Different Statin‐Based Lipid‐Lowering Strategies on C‐Reactive Protein Levels in Patients With Stable Coronary Artery Disease

  2024cites this paper
• Perioperative Changes in Plasma Nitrite and IL-6 Levels Predict Postoperative Atrial Fibrillation (POAF) and Acute Kidney Injury (AKI) after Cardiac Surgery

  2024cites this paper
• Statins for the Primary Prevention of Anthracycline Cardiotoxicity: A Comprehensive Review

  2024cites this paper
• A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action

  2024cites this paper
• The protective effects of statins in traumatic brain injury

  2024cites this paper
• Statins in Mitigating Anticancer Treatment-Related Cardiovascular Disease

  2024cites this paper
• Recent Insights in Pyrin Inflammasome Activation: Identifying Potential Novel Therapeutic Approaches in Pyrin-Associated Autoinflammatory Syndromes

  2023cites this paper
• Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity

  2023cites this paper
• Statin Gastroprotective Mechanisms Independent of Gastric Acid Suppression

  2023cites this paper
• Improving statins production: From non‐genetic strategies to genetic strategies

  2023cites this paper
• Effect of dietary inclusion of atorvastatin, garlic, and dill on growth performance, antioxidant defense, gut, and cardio-pulmonary function, and lipogenesis in broiler chickens

  2023cites this paper
• Strategies for the statins production in microbial cell factory:present and future

  2023cites this paper
• Mechanobiology of portal hypertension

  2023cites this paper
• Pleotropic effects of statins: the dilemma of wider utilization of statin

  2023cites this paper
• Pneumonia-Induced Inflammation, Resolution and Cardiovascular Disease: Causes, Consequences and Clinical Opportunities

  2023cites this paper
• Palmitoylation-dependent regulation of cardiomyocyte Rac1 signaling activity and minor effects on cardiac hypertrophy

  2023cites this paper
• Regulatory effects of curcumin on nitric oxide signaling in the cardiovascular system.

  2023cites this paper
• ROCK Inhibitors in Corneal Diseases and Glaucoma—A Comprehensive Review of These Emerging Drugs

  2023cites this paper
• Statins inhibit protein kinase D (PKD) activation in intestinal cells and prevent PKD1-induced growth of murine enteroids.

  2023cites this paper
• Paradoxical effects of statins on endothelial and cancer cells: the impact of concentrations

  2023influential citation
• Pleotropic properties of statins via angiogenesis modulation in cardiovascular disease.

  2022cites this paper
• Chronic cholesterol depletion increases F-actin levels and induces cytoskeletal reorganization via a dual mechanism

  2022cites this paper
• The EGFR/ErbB inhibitor neratinib modifies the neutrophil phosphoproteome and promotes apoptosis and clearance by airway macrophages

  2022cites this paper
• Molecular targets of statins and their potential side effects: Not all the glitter is gold.

  2022cites this paper
• Coronary Vasospastic Angina: A Review of the Pathogenesis, Diagnosis, and Management

  2022cites this paper
• Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.

  2022cites this paper
• Endothelial dysfunction: developmental mechanisms and therapeutic strategies

  2022cites this paper
• Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review

  2022cites this paper
• Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas

  2022cites this paper
• Exploring the Role of Plasma Lipids and Statins Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study

  2022cites this paper
• Association between statin use and rates of structural and functional loss in glaucoma

  2022cites this paper
• The Jekyll and Hyde of Cellular Senescence in Cancer

  2021cites this paper
• Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy

  2021cites this paper
• Regulation of Long Non-Coding RNAs by Statins in Atherosclerosis

  2021cites this paper
• S-Palmitoylation-Dependent Regulation of Cardiomyocyte Rac1 Signaling Activity and Cardiac Hypertrophy

  2021cites this paper
• Rho-Kinase-Hemmer als neue lokale Therapieoption beim primären Offenwinkelglaukom

  2021cites this paper
• Statins and Peripheral Arterial Disease: A Narrative Review

  2021cites this paper
• Rac GTPase Signaling in Immune-Mediated Mechanisms of Atherosclerosis

  2021cites this paper
• Off-Target Effect of Lovastatin Disrupts Dietary Lipid Uptake and Dissemination through Pro-Drug Inhibition of the Mesenteric Lymphatic Smooth Muscle Cell Contractile Apparatus

  2021cites this paper
• Determinants of the survival benefit associated with statins in patients with acute heart failure

  2021cites this paper
• Rho Kinase regulates neutrophil NET formation that is involved in UVB-induced skin inflammation

  2021cites this paper
• The wHole Story About Fenestrations in LSEC

  2021cites this paper
• Implications on the Therapeutic Potential of Statins via Modulation of Autophagy

  2021cites this paper
• Microvascular basis of cognitive impairment in type 1 diabetes.

  2021cites this paper
• Molecular basis of the effect of atorvastatin pretreatment on stem cell therapy in chronic ischemic diseases - critical limb ischemia.

  2021influential citation
• Effect of Pravastatin as an Adjunctive Therapeutic for Mitral Insufficiency with Hyperlipidemia in a Dog

  2021cites this paper
• A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with HMGCR Genetic Variation in Parkinson’s Disease

  2021cites this paper
• Erlanger Glaucoma Registry: Effect of a Long-Term Therapy with Statins and Acetyl Salicylic Acid on Glaucoma Conversion and Progression

  2021cites this paper
• Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies

  2021cites this paper
• Mechanical Regulation of Apoptosis in the Cardiovascular System

  2020cites this paper
• Targeting the RhoGTPase/ROCK pathway for the treatment of VHL/HIF pathway-driven cancers

  2020cites this paper
• The vital role for nitric oxide in intraocular pressure homeostasis.

  2020cites this paper
• Pravastatin‐induced changes in expression of long non‐coding and coding RNAs in endothelial cells

  2020cites this paper
• Endothelial Cell-Derived Microparticle

  2020cites this paper
• Statin Effects on Incidence, Treatment Success, and Mortality of Clostridium difficile Infections

  2020cites this paper
• EMERGING ANTENATAL THERAPIES FOR CONGENITAL DIAPHRAGMATIC HERNIA-INDUCED PULMONARY HYPERTENSION IN PRECLINICAL MODELS

  2020cites this paper
• Frailty Is Associated With Neutrophil Dysfunction Which Is Correctable With Phosphoinositol-3-Kinase Inhibitors

  2020cites this paper
• OvCa-Chip microsystem recreates vascular endothelium-mediated platelet extravasation in ovarian cancer.

  2020cites this paper
• Functional and morphological consequences after atorvastatin intake in a rat model of intracerebral haemorrhage

  2020cites this paper
• Are statins toxic or safe for kidney diseases? An updated mini-review study

  2020cites this paper
• Simvastatin inhibits the adipogenesis of bone marrow-derived mesenchymal stem cells through the downregulation of chemerin/CMKLR1 signaling

  2020cites this paper
• Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases

  2020cites this paper
• Cytoprotective Effect of Rho Kinase Inhibitors against Oxidative Stress inTrabecular Meshwork Cells

  2020cites this paper
• Indoxyl sulfate impairs valsartan-induced neovascularization☆

  2020cites this paper
• Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets—From Bench to Bed Site

  2020cites this paper
• Simvastatin Suppresses Human Breast Cancer Cell Invasion by Decreasing the Expression of Pituitary Tumor-Transforming Gene 1

  2020cites this paper
• Pleiotropic effects of statins: a focus on cancer.

  2020cites this paper
• Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications

  2019influential citation
• Evidence Supporting the Hypothesis That Inflammation-Induced Vasospasm Is Involved in the Pathogenesis of Acquired Sensorineural Hearing Loss

  2019cites this paper
• A review of systemic medications that may modulate the risk of glaucoma

  2019cites this paper
• An Update on the Association of Protein Kinases with Cardiovascular Diseases.

  2019cites this paper
• Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis

  2019cites this paper
• The neuroprotective effects of simvastatin on high cholesterol following traumatic brain injury in rats.

  2019cites this paper
• RhoGTPase in Vascular Disease

  2019cites this paper
• The Effects of Atorvastatin on the Migraine Pathophysiology in Nitroglycerin Induced Migraine in Ovariectomized Rats

  2019cites this paper
• Impact of statins on cellular respiration and de‐differentiation of myofibroblasts in human failing hearts

  2019cites this paper
• Coronary artery spasm — Clinical features, pathogenesis and treatment —

  2019cites this paper
• The role of pericytes in brain disorders: from the periphery to the brain

  2019influential citation
• The effects of statins with a high hepatoselectivity rank on the extra-hepatic tissues; new functions for statins.

  2019cites this paper
• A Single Bolus Rosuvastatin Accelerates Calcium Uptake and Attenuates Conduction Inhomogeneity in Failing Rabbit Hearts with Regional Ischemia-reperfusion Injury.

  2019cites this paper
• Differential Effects of Simvastatin on Membrane Organization and Dynamics in Varying Phases.

  2019cites this paper
• Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes

  2019cites this paper
• Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma.

  2019cites this paper
• Breast cancer metastatic dormancy and emergence, a role for adjuvant statin therapy

  2018cites this paper
• Protective effects of Schisandrin on high glucose-induced changes of RhoA and eNOS activity in human umbilical vein endothelial cells.

  2018cites this paper
• Beyond Lipids: Antiarrhythmic Effects of Statins

  2018cites this paper
• Rho‐associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease

  2018cites this paper
• Manipulating fenestrations in young and old liver sinusoidal endothelial cells

  2018cites this paper